FA
Fiducient Advisors’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $829K | Sell |
4,465
-991
| -18% | -$184K | 0.1% | 83 |
|
2025
Q1 | $1.14M | Buy |
5,456
+2,037
| +60% | +$427K | 0.14% | 72 |
|
2024
Q4 | $608K | Sell |
3,419
-1,095
| -24% | -$195K | 0.08% | 91 |
|
2024
Q3 | $892K | Buy |
4,514
+69
| +2% | +$13.6K | 0.1% | 76 |
|
2024
Q2 | $762K | Sell |
4,445
-3,415
| -43% | -$586K | 0.11% | 76 |
|
2024
Q1 | $1.43M | Buy |
7,860
+1,456
| +23% | +$265K | 0.28% | 36 |
|
2023
Q4 | $992K | Buy |
6,404
+1,160
| +22% | +$180K | 0.19% | 43 |
|
2023
Q3 | $782K | Buy |
+5,244
| New | +$782K | 0.04% | 57 |
|
2023
Q1 | – | Sell |
-1,980
| Closed | -$320K | – | 50 |
|
2022
Q4 | $320K | Buy |
1,980
+47
| +2% | +$7.6K | 0.09% | 133 |
|
2022
Q3 | $259K | Hold |
1,933
| – | – | 0.12% | 48 |
|
2022
Q2 | $296K | Sell |
1,933
-116
| -6% | -$17.8K | 0.11% | 69 |
|
2022
Q1 | $332K | Buy |
2,049
+155
| +8% | +$25.1K | 0.13% | 48 |
|
2021
Q4 | $256K | Sell |
1,894
-3,007
| -61% | -$406K | 0.08% | 51 |
|
2021
Q3 | $529K | Sell |
4,901
-200
| -4% | -$21.6K | 0.16% | 50 |
|
2021
Q2 | $575K | Sell |
5,101
-140
| -3% | -$15.8K | 0.18% | 36 |
|
2021
Q1 | $567K | Buy |
5,241
+140
| +3% | +$15.1K | 0.18% | 39 |
|
2020
Q4 | $547K | Buy |
+5,101
| New | +$547K | 0.2% | 37 |
|